Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- ELISA [1]
- Flow cytometry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- Ab169307 - Provider product page
- Provider
- Aladdin Scientific
- Product name
- Sintilimab (anti-PD-1)
- Antibody type
- Recombinant
- Description
- Pembrolizumab (anti-PD-1) is a potent, highly selective, fully humanized immunoglobulin (Ig) G4-kappa monoclonal antibody against PD-1 with potential immune checkpoint inhibitory and antineoplastic activities.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
- Reactivity
- Human
- Conjugate
- Unconjugated
- Vial size
- 100_g,10mg,1mg,5mg
- Concentration
- Lot by Lot
- Storage
- Store at -80_ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
No comments: Submit comment
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Sintilimab (anti-PD-1) (Ab169307) - ELISA Immobilized Recombinant Human PD-1 Protein (rp176241) at 1.0 μg/mL can bind Sintilimab (anti-PD-1) (Ab169307) with the EC50 of 16.34 ng/mL.
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Sintilimab (anti-PD-1) (Ab169307) - Flow Cytometry Flow Cytometry analysis of 5 μg/mL PHA stimulated 3 days human peripheral blood lymphocytes labelling PD-1 with Sintilimab (anti-PD-1) (Ab169307) conjugated with biotin (right panel) compared with Human IgG (Ab170213) conjugated with biotin - Isotype Control (left panel) and detected with SA-PE (rp156250).
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Sintilimab (anti-PD-1) (Ab169307) - Flow Cytometry Flow Cytometry analysis of 5 μg/mL PHA stimulated 3 days human peripheral blood lymphocytes labelling PD-1 (red) with Sintilimab (anti-PD-1) (Ab169307) conjugated with biotin and detected with SA-PE (rp156250). Blue - Isotype control, human IgG (Ab170213) conjugated with biotin. Black - Unlabelled control, cells without incubation with primary antibody.
